BOS172738: a novel highly potent and selective RET kinase inhibitor in phase 1 clinical development [abstract]
Others, such as the United Kingdom, may allow a 3-month supply
In the world of cutting-edge biological research, precision isn't just a goal
Gut-Brain Hormone Drugs Gain Attention in Addiction Research AUD remains a major public health challenge worldwide, with limited treatment options and modest efficacy of currently approved medications
Scales can be misleading during early treatmentyou may lose weight while maintaining or gaining muscle if you're training hard
In elite sport, financial inequality is already a factor (equipment, coaching, altitude camps), but a prescription medication adds a pharmaceutical dimension